Realtime | Geld | Brief | Zeit |
---|---|---|---|
4,250 | 4,380 | 28.06. |
Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
11.06. | Should You Buy Omada Health Stock After the OMDA IPO? | 6 | Barchart.com | ||
14.05. | Omda AS: Omda delivers 15% growth and 22% EBITDA margin | 1 | Oslo Børs | ||
14.05. | Omda Q1 2025 presentation: 15% revenue growth with EBITDA margin surging to 22% | 4 | Investing.com | ||
13.05. | Omda AS: Invitation to presentation of Omda's Q1-25 results | 2 | Oslo Børs | ||
25.04. | Omda AS: Minutes from the annual general meeting | 1 | Oslo Børs | ||
22.04. | Omda AS: Omda wins long term contract with Karolinska University Hospital | - | Oslo Børs | ||
OMDA Aktie jetzt für 0€ handeln | |||||
11.04. | Omda AS - Notice of Annual General Meeting | - | Oslo Børs | ||
11.04. | Omda AS: Omda delivered steadily increasing recurring revenues in 2024 | 1 | Oslo Børs | ||
19.03. | OMDA AS - Mandatory notification of trade by primary insiders | 1 | Oslo Børs | ||
07.03. | OMDA AS - Mandatory notification of trade by primary insiders | 1 | Oslo Børs | ||
26.02. | Omda AS: Announcement of Q4-24 Results | 1 | Oslo Børs | ||
20.02. | Omda AS: Invitation to presentation of Omda's Q4 results | 2 | Oslo Børs | ||
11.02. | Omda AS: New share capital registered | - | Oslo Børs | ||
07.02. | Omda AS: Omda completes acquisition of Aweria AB, a best-of-breed emergency department information system. | 4 | Oslo Børs | ||
31.01. | Omda AS: Omda completes acquisition of Dermicus AB, a provider of AI-enhanced telemedicine solutions. | 1 | Oslo Børs | ||
16.01. | Omda AS: Financial calendar | 1 | Oslo Børs |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
FRESENIUS MEDICAL CARE | 48,300 | +0,52 % | BERENBERG stuft FMC FRESENIUS MEDICAL CARE AG auf 'Buy' | HAMBURG (dpa-AFX Analyser) - Die Privatbank Berenberg hat das Kursziel für Fresenius Medical Care (FMC) von 55 auf 60 Euro angehoben und die Einstufung auf "Buy" belassen. Analystin Victoria Lambert... ► Artikel lesen | |
SIEMENS HEALTHINEERS | 46,900 | +0,13 % | EQS-CMS: Siemens Healthineers AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Siemens Healthineers AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b), Abs. 3 der Verordnung (EU) Nr. 596/2014, zuletzt geändert durch die Verordnung... ► Artikel lesen | |
MEDTRONIC | 73,67 | +0,23 % | Kaum Impulse für die Medtronic plc-Aktie (73,7742 €) | Der Kurs der dem Anteilsschein von Medtronic plc kommt kaum von der Stelle. Das Papier kostete zuletzt 85,73 US-Dollar. Die Wertschätzung der privaten und institutionellen Anlegern für die Aktie von... ► Artikel lesen | |
INTUITIVE SURGICAL | 459,00 | +0,71 % | Unglaubliche Prognose für Montag setzt Intuitive Surgical Aktionäre unter Druck. Jetzt Sondermeldung lesen und Montag reagieren! | ||
TELADOC HEALTH | 7,160 | -0,28 % | Aktien-Trading 4 Dummies - 3 Aktien. 2 Experten. 0 Langeweile (Hims & Hers, Teladoc & XTI Aerospace) | ||
THERMO FISHER | 349,20 | +0,13 % | Adial Pharmaceuticals, Inc: Adial Pharmaceuticals Secures U.S.-Based Manufacturing Through Agreements with Cambrex and Thermo Fisher Scientific for Drug Substance and Drug Product Supply | Scope of Agreement with Cambrex to Provide Ondansetron HCL Drug Substance Under FDA Approved Drug Master File Scope Of Agreement With Thermo Fisher to Provide Manufacturing Services Including Demonstration... ► Artikel lesen | |
ESSILORLUXOTTICA | 233,70 | -0,38 % | BERNSTEIN RESEARCH stuft EssilorLuxottica auf 'Neutral' | NEW YORK (dpa-AFX Analyser) - Das US-Analysehaus Bernstein Research hat die Einstufung für EssilorLuxottica auf "Market-Perform" mit einem Kursziel von 245 Euro belassen. Luca Solca befasste sich in... ► Artikel lesen | |
EUROFINS SCIENTIFIC | 60,80 | -0,23 % | Eurofins Scientific: Eurofins Announces the Success of Its New Schuldschein Issuance of €500m to Refinance its 2025 Schuldschein Loans | Regulatory News:
Eurofins Scientific (Paris:ERF) (EUFI.PA, rated Baa3 by Moody's and BBB- by Fitch), a global leader in bioanalytical testing, announces that it has successfully issued a new €500m... ► Artikel lesen | |
BECTON DICKINSON | 146,25 | +0,24 % | Becton, Dickinson and Company (BDX): A Bull Case Theory | ||
ALIGN TECHNOLOGY | 159,75 | -0,81 % | Reasons to Add Align Technology Stock to Your Portfolio Now | ||
INMODE | 12,345 | +1,73 % | InMode Ltd.: InMode Response Letter to DOMA by Moshe Mizrahy, CEO, Dated May 28, 2025 | YOKNEAM, Israel, May 28, 2025 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD) ("InMode"), a leading global provider of innovative medical technologies, today sent... ► Artikel lesen | |
ELEVANCE HEALTH | 319,70 | -1,90 % | Dividendenbekanntmachungen (25.06.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ASYMCHEM LABORATORIES TIANJIN CO LTD CNE100004Z06 1,2021 HKD 0,1319 EUR BANK FIRST CORPORATION US06211J1007 0,45 USD 0,3875 EUR BENETEAU... ► Artikel lesen | |
TENET | 146,00 | -1,35 % | Tenet Healthcare upgraded to BB- by S&P on improved performance | ||
BONESUPPORT | 25,760 | 0,00 % | Bonesupport Holding AB: Upcoming CEO change. Emil Billbäck will transfer to a role as Senior Advisor. Torbjörn Sköld will start as CEO effective September 1st, 2025 | BONESUPPORT, a leading company in orthobiologics for the management of bone injuries, today announces the coming transition of leadership at Bonesupport.
Lennart Johansson states: Emil Billbäck will... ► Artikel lesen | |
SURGICAL SCIENCE SWEDEN | 14,070 | -0,07 % | Surgical Science Sweden AB: Interim report January - March 2025: Strong growth despite macroeconomic uncertainties | First quarter 2025 (Jan-Mar)
Net sales amounted to SEK 250.7 (188.2) million, an increase of 33 percent compared with the corresponding period in the preceding year. SEK 18.3 million was acquired revenue.License... ► Artikel lesen |